Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-21-019733
Filing Date
2021-08-12
Accepted
2021-08-12 16:50:15
Documents
6
Effectiveness Date
2021-08-12
Reference 429
333-238233

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dffn20210811_s8.htm S-8 87584
2 EXHIBIT 4.8 ex_275157.htm EX-4.8 58320
3 EXHIBIT 5.1 ex_275301.htm EX-5.1 13286
4 EXHIBIT 23.1 ex_275237.htm EX-23.1 2470
5 logo02.gif GRAPHIC 4839
6 logo.jpg GRAPHIC 3384
  Complete submission text file 0001437749-21-019733.txt   174666
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258760 | Film No.: 211168346
SIC: 2834 Pharmaceutical Preparations